- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 39/29 - Hepatitis virus
Patent holdings for IPC class A61K 39/29
Total number of patents in this class: 1056
10-year publication summary
|
62
|
88
|
60
|
78
|
86
|
59
|
66
|
53
|
48
|
19
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Glaxosmithkline Biologicals S.A. | 1636 |
36 |
| The Trustees of the University of Pennsylvania | 4308 |
30 |
| The Governors of the University of Alberta | 862 |
29 |
| Janssen Sciences Ireland Unlimited Company | 395 |
27 |
| Xiamen University | 533 |
15 |
| The Regents of the University of California | 19812 |
13 |
| The Johns Hopkins University | 5642 |
13 |
| GlobeImmune, Inc. | 79 |
13 |
| Hvidovre Hospital | 57 |
13 |
| Transgene S.A. | 125 |
12 |
| The Macfarlane Burnet Institute for Medical Research and Public Health Ltd | 58 |
11 |
| Japan as Represented by Director-General of National Institute of Infectious Diseases | 86 |
10 |
| Oxford University Innovation Limited | 1501 |
10 |
| Tokyo Metropolitan Institute of Medical Science | 111 |
10 |
| Variation Biotechnologies, Inc. | 67 |
10 |
| Toko Yakuhin Kogyo Co., Ltd. | 34 |
10 |
| Toray Industries, Inc. | 6891 |
9 |
| University of Washington | 2317 |
9 |
| The Regents of the University of Michigan | 4670 |
8 |
| Centro de Ingenieria Genetica y Biotecnologia | 195 |
8 |
| Other owners | 760 |